Mesenchymal stromal cell therapy in liver disease: opportunities and lessons to be learnt?

27/08/2023
  • icon
  • icon
  • icon
Am J Physiol Gastrointest Liver Physiol 309: G791–G800, 2015.
First published August 27, 2015; doi:10.1152/ajpgi.00036.2015.Review
CALL FOR PAPERS | Intestinal Stem Cells in GI Physiology and Disease

Mesenchymal stromal cell therapy in liver disease: opportunities and lessons to be learnt?

Andrew Owen1 and Philip N. Newsome
National Institute for Health Research Birmingham Liver Biomedical Research Unit and Centre for Liver Research, Birmingham, United Kingdom; and Liver Unit, University Hospital Birmingham National Health Service Foundation Trust, Birmingham, United KingdomSubmitted 9 February 2015; accepted in final form 24 August 2015

6. The potential of MSCs in treating liver diseases
  • icon
  • icon
  • icon

Related articles

27/08/2023

9. The potential of MSCs in treating autoimmune diseases

Shining the light on clinical application of mesenchymal stem cell therapy in autoimmune diseases

View details

25/08/2023

1. Exosome therapy for liver disease

Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Ameliorate IL-6-Induced Acute Liver Injury Through miR-455-3p

View details

27/08/2023

7. MSCs in treating diabetes

Mesenchymal Stem Cells: An Excellent Candidate for the Treatment of Diabetes Mellitus

View details

26/08/2023

6. Exosome therapy for kidney disease

Potential and Therapeutic Efficacy of Cell-Based Therapy Using Mesenchymal Stem Cells for Acute/Chronic Kidney Disease

View details

27/08/2023

6. The potential of MSCs in treating liver diseases

Response-Related Factors of Bone Marrow-Derived Mesenchymal Stem Cells Transplantation in Patients with Alcoholic Cirrhosis

View details

27/08/2023

7. MSCs in treating diabetes

Long term effects of the implantation of Wharton’s jelly-derived mesenchymal stem cells from the umbilical cord for newly-onset type 1 diabetes mellitus

View details